FR2450873A1 - Nouveau plasmide, son procede d'isolement et culture de micro-organisme utilisee dans ce procede - Google Patents

Nouveau plasmide, son procede d'isolement et culture de micro-organisme utilisee dans ce procede

Info

Publication number
FR2450873A1
FR2450873A1 FR8004821A FR8004821A FR2450873A1 FR 2450873 A1 FR2450873 A1 FR 2450873A1 FR 8004821 A FR8004821 A FR 8004821A FR 8004821 A FR8004821 A FR 8004821A FR 2450873 A1 FR2450873 A1 FR 2450873A1
Authority
FR
France
Prior art keywords
puc6
plasmid
isolation method
microorganism culture
organism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8004821A
Other languages
English (en)
French (fr)
Other versions
FR2450873B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2450873A1 publication Critical patent/FR2450873A1/fr
Application granted granted Critical
Publication of FR2450873B1 publication Critical patent/FR2450873B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/82—Subcellular parts of microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
FR8004821A 1979-03-05 1980-03-04 Nouveau plasmide, son procede d'isolement et culture de micro-organisme utilisee dans ce procede Granted FR2450873A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/017,812 US4273875A (en) 1979-03-05 1979-03-05 Plasmid and process of isolating same

Publications (2)

Publication Number Publication Date
FR2450873A1 true FR2450873A1 (fr) 1980-10-03
FR2450873B1 FR2450873B1 (enExample) 1983-02-25

Family

ID=21784674

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8004821A Granted FR2450873A1 (fr) 1979-03-05 1980-03-04 Nouveau plasmide, son procede d'isolement et culture de micro-organisme utilisee dans ce procede

Country Status (7)

Country Link
US (1) US4273875A (enExample)
JP (1) JPS55120600A (enExample)
DE (1) DE3005226A1 (enExample)
FR (1) FR2450873A1 (enExample)
GB (1) GB2043652B (enExample)
IT (1) IT1130921B (enExample)
NL (1) NL8001175A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064350A1 (en) * 1981-04-28 1982-11-10 Takeda Chemical Industries, Ltd. Plasmid and production thereof

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035914A3 (en) * 1980-03-12 1982-06-16 The Upjohn Company Plasmid vectors, plasmids and their preparation, and cloning processes using them
US4340674A (en) * 1980-05-05 1982-07-20 The Upjohn Company Cointegrate plasmids and their construction from plasmids of Escherichia and Streptomyces
US4332900A (en) * 1980-10-01 1982-06-01 The Upjohn Company Construction of co-integrate plasmids from plasmids of Streptomyces and Escherichia
EP0058002A3 (en) * 1981-01-26 1983-06-29 The Upjohn Company Process for stabilising potential plasmid vectors and novel plasmids
DE3117131A1 (de) * 1981-04-30 1982-11-25 Hoechst Ag, 6000 Frankfurt "plasmid psg 2 und verfahren zu seiner gewinnung"
JPS57188600A (en) * 1981-05-15 1982-11-19 Meiji Seika Kaisha Ltd Novel actinomycetic plasmid
JPS57206699A (en) * 1981-06-10 1982-12-18 Takeda Chem Ind Ltd Plasmid patm 3 and its preparation
US4393137A (en) * 1981-06-22 1983-07-12 The Upjohn Company Cloning plasmid for streptomyces
DE3128669A1 (de) * 1981-07-20 1983-02-03 Hoechst Ag, 6000 Frankfurt "plasmid p svh 1 und seine verwendung"
US4513086A (en) * 1981-10-15 1985-04-23 Eli Lilly And Company Cloning vectors for use in streptomyces and related organisms
US4416994A (en) * 1981-10-19 1983-11-22 Eli Lilly And Company Plasmid pEL7 and related cloning vectors for use in streptomyces and related organisms
JPS58157800A (ja) * 1982-03-16 1983-09-19 Sankyo Co Ltd プラスミドｐｓａｎ１８１
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPS592689A (ja) * 1982-06-04 1984-01-09 Handai Biseibutsubiyou Kenkyukai 強力な遺伝子発現能を有する新規レプリコンの作成法
JPS60145685A (ja) 1984-01-09 1985-08-01 Nec Corp 分布帰還型半導体レ−ザ
US4778759A (en) * 1982-07-09 1988-10-18 Boyce, Thompson Institute For Plant Research, Inc. Genetic engineering in cyanobacteria
WO1984001150A1 (en) 1982-09-16 1984-03-29 Amgen Avian growth hormones
US4513085A (en) * 1982-10-07 1985-04-23 Eli Lilly And Company Functionally independent cloning vectors for use in streptomyces
US4468462A (en) * 1982-12-22 1984-08-28 Eli Lilly And Company Vectors for cloning in streptomyces
US4559300A (en) * 1983-01-18 1985-12-17 Eli Lilly And Company Method for using an homologous bacillus promoter and associated natural or modified ribosome binding site-containing DNA sequence in streptomyces
EP0117694A1 (en) * 1983-02-25 1984-09-05 The Upjohn Company Plasmids and plasmid vectors
US4703009A (en) * 1983-03-08 1987-10-27 Merck & Co., Inc. RDNA cloning vector pVE1, deletion and hybrid mutants and recombinant derivatives thereof products and processes
US4791064A (en) * 1983-07-07 1988-12-13 Smithkline Beckman Corporation Plasmids from nocardia
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
UA54363C2 (uk) 1984-09-28 2003-03-17 Кірін-Амген, Інк Виділена молекула днк, яка кодує людський еритропоетин (варіанти), біологічно функціональний кільцевий плазмідний або вірусний днк-вектор, штам еукаріотичних клітин-хазяїв (варіанти), спосіб одержання поліпептиду, фармацевтична композиція
US5149639A (en) * 1986-03-24 1992-09-22 Abbott Laboratories Biologically pure cultures of streptomyces and use thereof in macrolide antibiotic production
US4874748A (en) * 1986-03-24 1989-10-17 Abbott Laboratories Cloning vectors for streptomyces and use thereof in macrolide antibiotic production
US6156953A (en) 1997-06-03 2000-12-05 University Of Chicago Plant artificial chromosome compositions and methods
WO2002080848A2 (en) * 2001-04-09 2002-10-17 Mayo Foundation For Medical Education And Research Methods and materials for cancer treatment
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
US8858952B2 (en) 2009-02-19 2014-10-14 Mayo Foundation For Medical Education And Research Methods and materials for generating T cells
EP2409155A1 (en) 2009-03-15 2012-01-25 Technion Research and Development Foundation, Ltd. Soluble hla complexes for use in disease diagnosis
AU2013221309B2 (en) 2012-02-17 2017-03-30 Mayo Foundation For Medical Education And Research Methods and materials for generating CD8+ T cells having the ability to recognize cancer cells expressing a HER2/neu polypeptide
EP3211002B1 (en) 2012-03-21 2020-05-13 Ben-Gurion University of The Negev Peptides derived from the ectodomain of nkp46
JP6744225B2 (ja) 2014-02-14 2020-08-19 シンヴィヴォ コーポレイション ハイブリッドタンパクおよびその使用
EP3188716B1 (en) 2014-09-03 2022-10-26 GeneSegues, Inc. Therapeutic nanoparticles and related compositions, methods and systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2226465A1 (enExample) * 1973-04-23 1974-11-15 Upjohn Co

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2226465A1 (enExample) * 1973-04-23 1974-11-15 Upjohn Co

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/77 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064350A1 (en) * 1981-04-28 1982-11-10 Takeda Chemical Industries, Ltd. Plasmid and production thereof

Also Published As

Publication number Publication date
US4273875A (en) 1981-06-16
FR2450873B1 (enExample) 1983-02-25
NL8001175A (nl) 1980-09-09
JPS55120600A (en) 1980-09-17
GB2043652A (en) 1980-10-08
IT1130921B (it) 1986-06-18
GB2043652B (en) 1982-11-17
IT8020327A0 (it) 1980-03-03
DE3005226A1 (de) 1980-09-18

Similar Documents

Publication Publication Date Title
FR2450873A1 (fr) Nouveau plasmide, son procede d'isolement et culture de micro-organisme utilisee dans ce procede
DE69332377T2 (de) Verfahren zur modifizierung rekombinanter polypeptide
DE3786918T2 (de) Expression des klonierten lysostaphingens.
EP0283961A3 (en) Process and composition for purifying arsine, phosphine, ammonia and inert gases to remove lewis acid and oxidant impurities therefrom
DE60029091D1 (de) Verfahren zur herstellung von diphtheria toxin
ATE244279T1 (de) Verfahren zur synthese von phthalocyaninverbindungen
EP0775750B1 (de) Herstellung von Proteinen aus Pro-Proteinen durch Fusionsproteine abgeleitet von Furin oder Furinanalogen
Mitchell Norcoronatine and N-coronafacoyl-L-valine, phytotoxic analogues of coronatine produced by a strain of Pseudomonas syringae pv. glycinea
FI925940A0 (fi) Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta
BG101620A (en) Dna purification by the formation of a triple spiral with immobilized oligonucleotide
EP0492497B1 (de) Verfahren zur Acylierung von Alkoholen mit einem immobilisierten Pseudomonas-Lipase
EP0207402A2 (de) Verfahren zur Herstellung von Proteinen und Polypeptiden
FR2452516A1 (fr) Nouveau plasmide essentiellement pur et son procede d'isolement
DE69732772T2 (de) Enzymatisches verfahren zur stereoselektiven herstellung von therapeutischen amiden
FR2452517A1 (fr) Nouveau plasmide essentiellement pur et son procede de production
FR2452518A1 (fr) Nouveau plasmide essentiellement pur et son procede d'isolement
FR2452519A1 (fr) Nouveau plasmide essentiellement pur et son procede d'isolement
FR2451941A1 (fr) Nouveau plasmide et son procede d'isolement
Ihara et al. Enantioselective ester hydrolysis by hydroxamic acids of N-benzyloxycarbonyl-L-amino acids or optically active amines in cetyltrimethylammonium bromide micelles
EP0169505B1 (en) Process for preparing oligopeptide
DE69211340T2 (de) Verfahren zur enzymatischen herstellung von makrolakton
ATE173922T1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
ATE199243T1 (de) Verfahren zur herstellung von (meth)acrylsäureestern
EP0032675A3 (en) Microbiologically produced polypeptide having the amino acid sequence of primate proinsulin, dna and plasmids coding for this sequence, microorganisms containing this genetic information, and process for their production
DE2706490A1 (de) Neue carbonsaeureester

Legal Events

Date Code Title Description
ST Notification of lapse